Search

29 results for “Editorial”

• EditorialOpen Access

  Valethamate bromide: Is there any proof of efficacy and safety for its use in labor?

  Gitanjali B

  Vol. 1 · Issue 1 · pp. 2–3

  https://doi.org/10.4103/0976-500X.64528
  Full text ↗PDF

• EditorialOpen Access

  A Glimpse into the Diverse Horizons of Pharmacological Research: Insights From the Latest Issue

  Mueen Ahmed

  Vol. 14 · Issue 3 · pp. 169–170

  https://doi.org/10.1177/0976500X231221181
  Full text ↗PDF

• EditorialOpen Access

  Essential medicines for children: Should we focus on a priority list of medicines for the present?

  Gitanjali B

  Vol. 2 · Issue 1 · pp. 1–2

  https://doi.org/10.4103/0976-500X.77073
  Full text ↗PDF

• EditorialOpen Access

  Principles and practice of plagiarism: Perpetrators’ perspective

  Amitav Banerjee

  Vol. 6 · Issue 2 · pp. 61–62

  https://doi.org/10.4103/0976-500X.155480
  Full text ↗PDF

• CorrespondenceOpen Access

  Valethamate bromide: Conflicting evidence and continuing use

  Thirunavukkarasu Arun Babu, Vijayan Sharmila

  Vol. 1 · Issue 2 · pp. 120–120

  https://doi.org/10.4103/0976-500X.72365
  Full text ↗PDF

• Guest EditorialOpen Access

  Hypothesis to Citation: Exploring the Intersections of Research Methodology, Indexed Publications, and Scientific Ethics

  Pitchai Balakumar, Hema Subramonian, Murugan Thangiah, Saravanan Pandiaraj, Shubhada Nagarkar, P.K. Srividhya, Arasu Chellaiah, Gowraganahalli Jagadeesh

  Vol. 16 · Issue 4 · pp. 353–361

  https://doi.org/10.1177/0976500X251363677
  Full text ↗PDF

• EditorialOpen Access

  The national essential medicines list of India: Time to revise and purge the mistakes

  Gitanjali B

  Vol. 1 · Issue 2 · pp. 73–74

  https://doi.org/10.4103/0976-500X.72346
  Full text ↗PDF

• EditorialOpen Access

  Source of Support: Nil, Confl ict of Interest: None declared.

  Gitanjali B.

  Vol. 2 · Issue 2 · pp. 71–73

  https://doi.org/10.4103/0976-500X.81894
  Full text ↗PDF

• Short ReviewOpen Access

  Progress Update on the Epidemiology of COVID-19 Variants and the Assessment Status of Developed Vaccines

  Katharigatta N. Venugopala

  Vol. 13 · Issue 3 · pp. 293–299

  https://doi.org/10.1177/0976500X221138393
  Full text ↗PDF